DCF Help
How do you do a DCF for a company that has negative earnings? Wouldn't you just focus more on comps analysis & PT instead of DCF in this case?
Also as a follow up question, when would you not use a DCF?
Trending Content - Investment Banking Forum
| +194 | UBS preparing for a October Layoff Massacre | 177 | 1h |
| +83 | Work and Suicide | 37 | 24m |
| +57 | A Message to Students Who Think this Job Will Fix Their Life | 12 | 18m |
| +52 | Is 7 years in banking enough to retire, or am I delusional? | 31 | 7h |
| +47 | Do actual investment bankers despise IB TikTokers as much as I think they do? | 28 | 21h |
| +32 | UBS IB Balance Sheet Set to take a Hit | 9 | 6h |
| +27 | Should I escape the matrix | 5 | 1d |
| +26 | Negotiating VP Sign-On Bonus (NOT Tied to Deferred Comp)? | 23 | 6h |
| +23 | LevFin, First Interview (Ever) Help! | 5 | 1d |
| +21 | JPMorgan Banker Hospitalized | 7 | 2d |
Career Resources
Yes, you are right— you would not use a DCF in this case because positive cash flows (the very things you are using to estimate value) are non-existent. I guess you could make a case for running a DCF on a pre-earnings company if you were extremely confident in positive earnings predictions in the years ahead... but that’s definitely a stretch and I’m not sure anyone would give it much weight. Much better to use comps and PTs.
You typically don’t use a DCF for pre-earnings companies (as discussed) or companies that have very volatile earnings that are hard to predict with any level of accuracy.
DCF: The issue isn't negative earnings so much as the FCF being unstable. Note that you may have negative earnings with positive cash flows but this still insufficient. Negative earnings implies that company isn't stable yet. Negative earnings aren't sustainable long-term so you know the company is either still in growth stage or distressed/on a downturn. Either way, the company's FCF will be unstable and you cannot use the perpetuity growth method to conclude a DCF valuation until the company has stabilized its growth.
You'd focus on comps multiples off of stabilized positive values - for TEV, is EBITDA positive? If not, use a sales multiple.
Earnings may be negative but what about FCF? You could try P/FCF. Lots of tech SaaS are earnings negative but FCF positive and you could slap on 20-30x multiple to get an equity valuation.
You can still do a DCF with negative earnings, this happens all the time for clinical-stage life sciences companies. You need to push out your time horizon.
Can you explain in more detail how you would do so? I am relatively new to the valuation methodologies?
Odio iusto explicabo fuga dolor quos velit. Cumque quae non neque alias iure harum. Quo quia illo eaque deleniti harum est architecto amet.
Maiores molestiae dolore voluptatem et ipsa. Architecto dolores laudantium voluptatem. Architecto architecto est velit odio aut nihil. Ut nihil cum neque esse est.
Quidem unde veritatis et vero. Iste excepturi qui omnis aliquid aperiam. Numquam quia veritatis molestiae officiis. Enim provident laborum nobis tempora soluta. Alias quo architecto ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...